All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

@holaraquelita's HCG trigger shot video, fact-checked

RAQUELITA

TikTok creator

10.2K viewsWatch on TikTok→

Quick answer

The creator documented a dual trigger protocol using simultaneous hCG and GnRH agonist injections 36 hours before oocyte retrieval, followed by a separate physician-recommended hCG booster shot. Dual trigger protocols have evidence support for improving mature oocyte yield in suboptimal responders, with the GnRH agonist component typically selected to reduce OHSS risk compared to hCG-only triggers. The addition of a supplemental hCG booster on top of a dual trigger is a less standardized clinical decision that carries OHSS risk considerations and should be individualized based on patient response and history.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @holaraquelita actually say?

She said she did a "dual trigger" at 1:30 a.m., 36 hours before egg retrieval, with one injection in her belly and one in her glute, both given at the same time. Then, separately, her doctor recommended an additional HCG booster shot on top of that. She described it as an "extra little boost beforehand" and showed the injection needle on camera.

To be clear about what she's claiming: a dual trigger plus a separate HCG booster, all as part of a single egg freezing cycle. That's three trigger-related injections, not just the standard one. She's not claiming any specific dose or making medical recommendations. She's documenting her own cycle, which matters for how we evaluate this.

Does the science back this up?

The dual trigger protocol is real, well-studied, and increasingly common. The booster is a legitimate but more niche addition. The 36-hour timing before retrieval is textbook accurate.

The standard trigger for egg freezing has traditionally been hCG alone, which mimics the LH surge and initiates final oocyte maturation. The dual trigger, combining hCG with a GnRH agonist (typically leuprolide), was examined by Shapiro et al. (2011, Fertility and Sterility) and showed improved mature oocyte yield in certain patient populations, particularly those with a history of suboptimal response. The mechanism makes sense: the GnRH agonist fires a flare of endogenous LH and FSH on top of the exogenous hCG hit.

As for an additional hCG booster on top of a dual trigger, this is less standardized. Some clinicians use it in low responders or when follicular development suggests the need for extra luteinization support. It's not a fringe idea, but the evidence base is thinner than for the dual trigger itself.

What did they get wrong (or right)?

She got the core facts right. The 36-hour interval between trigger and retrieval is the clinical standard. Kummer et al. (2013, Fertility and Sterility) confirmed that oocyte maturation peaks around 36 hours post-hCG trigger, and deviating significantly from that window reduces yield. She's accurate there.

The dual trigger protocol she described, one injection per site simultaneously, is also consistent with how it's administered. You don't stagger them; they go together to coordinate the hormonal surge.

Where things get slightly murky is the framing of the booster as just giving her "an extra little boost." That's casual language for something that is actually a pharmacological decision with real implications. Adding hCG on top of a dual trigger raises the theoretical risk of ovarian hyperstimulation syndrome (OHSS), particularly in high responders. The GnRH agonist component of a dual trigger is actually chosen in part because it produces a shorter LH surge and lower OHSS risk than hCG alone. Layering more hCG back on top partially offsets that advantage. She's not wrong that her doctor recommended it, and low responders may genuinely benefit, but the framing undersells the clinical nuance involved.

What should you actually know?

If you're considering egg freezing and your clinic mentions a trigger shot, know that there is no single universal protocol. What trigger you get, and when, should depend on your ovarian reserve, your response to stimulation, and your OHSS risk profile.

  • The dual trigger (hCG plus GnRH agonist) is supported by evidence for improving mature egg yield in certain patients, particularly those who have had poor responses before.
  • An additional hCG booster is a clinical decision that requires weighing benefits against OHSS risk. It is not appropriate for everyone.
  • The 36-hour timing window between trigger and retrieval is not flexible. Missing it in either direction measurably reduces outcomes.
  • Self-administering simultaneous injections in two sites, as she did alone at 1:30 a.m., is something most clinics will train you on, but don't assume you can figure it out without instruction.
  • HCG in the context of egg freezing is being used to trigger ovulation, not as a fertility treatment for hypogonadism. These are pharmacologically the same molecule but used in completely different clinical contexts with different goals and monitoring requirements.

Bottom line

This video is largely accurate and reasonably responsible for a first-person fertility diary. She's not making medical claims about what others should do. The 36-hour trigger timing is correct, the dual trigger protocol is evidence-supported, and the additional booster, while less standardized, is a real clinical tool. The main issue is that breezy language around a triple-hormone event before a surgical procedure doesn't capture how individualized these decisions need to be. If your doctor recommends something different from what you see on TikTok, that difference is probably intentional.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @holaraquelita's HCG trigger shot video, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@holaraquelita's HCG trigger shot video, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

The creator documented a dual trigger protocol using simultaneous hCG and GnRH agonist injections 36 hours before oocyte retrieval, followed by a separate physician-recommended hCG booster shot.

FormBlends verdict

The creator documented a dual trigger protocol using simultaneous hCG and GnRH agonist injections 36 hours before oocyte retrieval, followed by a separate physician-recommended hCG booster shot. Dual trigger protocols have evidence support for improving mature oocyte yield in suboptimal responders, with the GnRH agonist component typically selected to reduce OHSS risk compared to hCG-only triggers. The addition of a supplemental hCG booster on top of a dual trigger is a less standardized clinical decision that carries OHSS risk considerations and should be individualized based on patient response and history.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator documented a dual trigger protocol using simultaneous hCG and GnRH agonist injections 36 hours before oocyte retrieval, followed by a separate physician-recommended hCG booster shot. Dual trigger protocols have evidence support for improving mature oocyte yield in suboptimal responders, with the GnRH agonist component typically selected to reduce OHSS risk compared to hCG-only triggers. The addition of a supplemental hCG booster on top of a dual trigger is a less standardized clinical decision that carries OHSS risk considerations and should be individualized based on patient response and history.
  • The 36-hour hCG-to-retrieval interval is not arbitrary. Kummer et al. (2013) showed deviating from it meaningfully reduces mature oocyte yield.
  • Dual trigger protocols combining hCG and GnRH agonist are supported by evidence for suboptimal responders, with Shapiro et al. (2011) showing improved maturation rates.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The 36-hour hCG-to-retrieval interval is not arbitrary. Kummer et al. (2013) showed deviating from it meaningfully reduces mature oocyte yield.
  • Dual trigger protocols combining hCG and GnRH agonist are supported by evidence for suboptimal responders, with Shapiro et al. (2011) showing improved maturation rates.
  • Adding a standalone hCG booster on top of a dual trigger is practiced but not standard of care. It requires individual risk assessment, particularly regarding OHSS in high responders.
  • HCG in egg freezing triggers ovulation and is pharmacologically distinct in purpose from hCG used in hypogonadism or TRT-adjacent protocols, even though it is the same molecule.
  • OHSS risk exists on a spectrum. The GnRH agonist in a dual trigger is partly selected to reduce that risk. Additional hCG reintroduces some of that risk and should not be self-decided.
  • Self-administering simultaneous bilateral injections requires clinic training. The casual framing in this video should not be interpreted as a guide to DIY administration.
  • Trigger protocol selection, dual trigger, hCG only, or with a booster, should be based on your specific cycle response, ovarian reserve markers, and OHSS risk history, not TikTok comparisons.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

RAQUELITA · TikTok creator

10.2K views on this video

That extra little HCG booster trigger🙃 #chicago #eggfreezing #fertility #fertilityjourney #fertilityawareness #ovaeggfreezing

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by RAQUELITA, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.